Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$1.8 - $2.56 $42,366 - $60,254
-23,537 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$2.04 - $3.74 $2,947 - $5,404
1,445 Added 6.54%
23,537 $56,000
Q1 2020

May 15, 2020

BUY
$1.5 - $4.59 $10,462 - $32,015
6,975 Added 46.14%
22,092 $64,000
Q4 2019

Feb 14, 2020

BUY
$3.89 - $5.15 $58,805 - $77,852
15,117 New
15,117 $60,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.8B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Old Well Partners, LLC Portfolio

Follow Old Well Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Well Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Well Partners, LLC with notifications on news.